Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?
Joint Authors
Yan, Quanxiang
Ning, Libing
Jian, Yu
Yang, Wencong
Yuan, Qinghua
Du, Zhimin
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-04-25
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Coronary artery aneurysms (CAAs) are uncommon in coronary angiography, and left main coronary artery aneurysms are rare.
There is no consensus for the treatment of CAAs.
A young patient with left coronary artery aneurysm diagnosed by coronary angiography and with recurrent acute myocardial infarction was treated with rivaroxaban and aspirin.
The patient had no angina for 6 months.
Novel oral anticoagulants combined with antiplatelet agents may be appropriate for the treatment of CAAs.
American Psychological Association (APA)
Yan, Quanxiang& Ning, Libing& Jian, Yu& Yang, Wencong& Yuan, Qinghua& Du, Zhimin. 2020. Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?. Case Reports in Medicine،Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1148501
Modern Language Association (MLA)
Yan, Quanxiang…[et al.]. Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?. Case Reports in Medicine No. 2020 (2020), pp.1-4.
https://search.emarefa.net/detail/BIM-1148501
American Medical Association (AMA)
Yan, Quanxiang& Ning, Libing& Jian, Yu& Yang, Wencong& Yuan, Qinghua& Du, Zhimin. Could the Novel Oral Anticoagulants Be Used for Coronary Artery Aneurysm?. Case Reports in Medicine. 2020. Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1148501
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1148501
